Clinical Trials Browser

OTHER × Lymphoma × volagidemab × Clear all

NCT04253223 2021-06-11

A Study to Determine Safety and Efficacy of (REMD-477) in Controlling Hyperglycemia Due to Copanlisib

Phase 1 Terminated

Hyperglycemia, Lymphoma